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Abstract 
Background: The relationships of many factors with cardiovascular autonomic function 
(CVAF) outcome parameters may not be uniform across the entire distribution of the 
outcome. We examined how demographic and clinical factors varied with different subgroups 
of CVAF parameters. 
Methods: Quantile regression was applied to a cross-sectional analysis of 4,167 adults (56% 
male; age range, 50-84 years) from 4 ethnic groups (3,419 New Zealand European, 303 
Pacific, 227 Maori and 218 South Asian) and without diagnosed cardiac arrhythmia. Pulse 
rate variability (root mean square of successive differences (RMSSD) and standard deviation 
of pulse intervals) and baroreflex sensitivity were response variables. Independent variables 
were age, sex, ethnicity, brachial and aortic blood pressure (BP) variables, BMI and diabetes. 
Results: Ordinary linear regression showed that age, sex, Pacific and Maori ethnicity, BP 
variables, BMI and diabetes were associated with CVAF parameters. But quantile regression 
revealed that, across CVAF percentiles, the slopes for these relationships: 1) varied by more 
than 10-fold in several cases and sometimes changed direction and, 2) noticeably differed in 
magnitude often (by >3-fold in several cases) compared to ordinary linear regression 
coefficients. For instance, age was inversely associated with RMSSD at the 10th percentile of 
this parameter (β=-0.12 ms/year, 95% confidence interval=-0.18 to -0.09 ms/year) but had a 
positive relationship at the 90th percentile (β=3.17 ms/year, 95% confidence interval=2.50 to 
4.04 ms/year). 
Conclusions: The relationships of demographic and clinical factors with CVAF parameters 
are, in many cases, not uniform. Quantile regression provides an improved assessment of 
these associations. 
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Introduction 
Cardiovascular autonomic function (CVAF) is an important aspect of cardiovascular health. 
Variables reflecting this, such as heart rate variability (HRV) and baroreflex sensitivity 
(BRS), predict risk of cardiovascular events.1-3 Impaired autonomic function has been 
identified as a factor in the pathogenesis of hypertension. In support of this, both 
parasympathetic and sympathetic activity have physiological effects on blood pressure (BP) 4 
and low HRV is associated with greater risk of incident hypertension.5 Further, impaired 
HRV predicts new-onset atrial fibrillation,6 which is associated with an increased risk of 
cardiovascular morbidity and mortality.7,8 Identifying determinants of CVAF is thus useful for 
understanding how factors may impact on cardiovascular health. 
Factors that may influence CVAF are age, sex, ethnicity, BP, body mass index (BMI) 
and diabetes;9-12 all are well-known cardiovascular risk factors. However, analyses in past 
studies of CVAF were carried out using ordinary linear regression, which models only the 
mean of this outcome. Important relationships may be missed because cardiovascular 
disease/events correlate positively with HRV parameters at high levels of these measures 
3,13,14 but inversely at lower levels.1,3,5 Thus, the relationship between CVAF and 
cardiovascular events is not uniform across the entire distribution of the former. Further, HRV 
measures frequently have skewed distributions,10 suggesting that determinants of these 
parameters may affect specific regions (percentiles) of these distributions more than others. 
For example, a positively skewed distribution might arise, in part, from a factor particularly 
affecting HRV values at the upper end of the distribution. In view of this, a more 
comprehensive and useful evaluation of associations between various factors and HRV 
measures would be attained by carrying out subgroup analyses in different regions of the 
HRV distribution. 
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Another gap in prior research is knowledge of whether CVAF varies with Polynesian 
and South Asian ethnicities. This is significant as these ethnic groups have a higher 
prevalence of cardiovascular disease relative to European (white) populations.15,16 Further, 
previous studies have evaluated relationships of CVAF with brachial BP but not with other 
arterially-related parameters. These include augmentation index, peak reservoir pressure and 
excess pressure integral; parameters which may predict cardiovascular burden independently 
of brachial BP.17-19 
We sought to examine how CVAF parameters vary with demographic and clinical 
factors. To build on past research, these associations were evaluated across various percentiles 
of the distribution of these CVAF measures, we included participants of Polynesian (Maori 
and Pacific) and South Asian ethnicity, and measurements taken from the aortic pressure 
waveform were included in analyses. 
 
Methods 
Participants 
The present study is an analysis of baseline data collected in the ViDA (Vitamin D 
Assessment) study, a randomised controlled trial of the health effects of vitamin D 
supplementation. Inclusion criteria were men and women aged 50-84 years and resident in 
Auckland at recruitment. Exclusion criteria included: 1) diagnosis of a terminal illness and/or 
in hospice care, 2) intending to leave New Zealand during the follow-up period, 3) taking 
vitamin D supplements (including cod liver oil) of >600 IU per day, 4) history of renal stones, 
hypercalcaemia, or medical conditions that can cause hypercalcaemia and 5) baseline serum 
calcium >2.50 mmol/L. All baseline data were collected between 2011 and 2012. Ethics 
approval was provided by the Ministry of Health Multi-region Ethics committee. Written, 
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informed consent was obtained from each participant. Full details of the study design have 
been published elsewhere.20 
 
Demographic and non-BP, clinical variables 
All measurements were carried out by trained staff using a standardised protocol. 
Questionnaires administered by interviewers were used to collect data on age, sex, ethnicity 
(defined by self-identification) and history of diabetes. Past diagnosis of a cardiac arrhythmia 
was also determined from these questionnaires and from Ministry of Health hospitalisation 
data; since HRV assessment is traditionally applied to people without a cardiac arrhythmia. 
Without shoes and in light clothing, height (±0.1 cm) was measured with a stadiometer and 
weight (±0.1 kg) with digital scales. Body mass index (BMI) was calculated as weight 
(kg)/height (m)2. 
To adjust for the effect of antihypertensive medications on the CVAF parameters, 
prescriptions dispensed for days of supply that encompassed the interview date were recorded 
from Ministry of Health data. Antihypertensive medicines were categorised into beta-blockers 
and non-beta-blockers since these drug classes may differentially affect CVAF 
parameters.21,22 
 
BP variables 
After 15 minutes resting and while sitting, brachial BP (±1 mmHg) was measured three times 
with an Omron T9P oscillometric device (Omron Healthcare, Kyoto, Japan) above the cubital 
fossa of the left arm and the mean of the two closest measurements was used for analyses. 
Suprasystolic oscillometry was carried out using a BP+ device (Uscom, Sydney, Australia) 
(formerly known as a R6.5 cardiovascular monitor; Pulsecor, Auckland, New Zealand), with 
an appropriately-sized cuff positioned over the left upper arm. The BP+ device has been 
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shown to: 1) yield central systolic blood pressures that are highly correlated with those 
assessed by catheter measurement at the ascending aorta or aortic arch 23 and, 2) measure 
central systolic BP with good intratest and intertest reliability.24 To improve the quality of the 
waveforms used in analyses, we decided a priori to exclude readings with a signal-to-noise 
ratio of <6 dB. 
Augmentation index (AIx), a predictor of CV events,17 was calculated from the aortic 
pressure waveform using custom-written Matlab software (Mathworks, Natick, MA). Aortic 
pressure was separated into reservoir and wave components using custom-written Matlab 
software. Reservoir pressure was calculated from pressure measurements only, as described 
elsewhere.18 Peak reservoir pressure was calculated as the amplitude of the reservoir pressure 
waveform, which has been found to associate positively with the risk of cardiovascular events 
independently of brachial BP.19 Excess pressure was calculated as measured aortic pressure 
minus reservoir pressure.19 The integral of the excess pressure waveforms (area under these 
waveforms) over the cardiac cycle was used to calculate excess pressure integral (EPI). EPI 
measures pressure associated with excess ventricular work and has been shown to predict CV 
events independently of brachial SBP.18 
 
CVAF measures 
Pulse rate variability was assessed from the variability of the beat duration of the aortic 
pressure waveforms derived from the BP+ device. The waveforms spanned approximately 10 
seconds; thus analysis was performed on approximately 10 to 12 pulse intervals, a period 
adequate for valid measurement of HRV.25-29 Two time-domain measures were used: root 
mean square of successive differences (RMSSD) and standard deviation (SD) of pulse 
intervals (in ms; analogous to SD of NN intervals of an electrocardiographic record).30 
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RMSSD (in ms) was calculated as the square root of the mean of the squared differences of 
the duration of successive pulse intervals and reflects parasympathetic activity.30 
BRS was assessed using the sequence method, which establishes the slope of the 
relationship between changes in pulse interval and SBP across successive cardiac cycles.31,32 
Pulse intervals were paired with the SBP (maximum amplitude of the pressure waveform) of 
the preceding cardiac cycle (that is, a one-beat delay), as described elsewhere.31,32 Instances in 
which SBP and pulse intervals (PI) both increased (+PI/+SBP) or decreased (-PI/-SBP) from 
one beat to the next were detected. Due to the limited number of beats, we did not enforce the 
practice 31 that these changes had to occur over at least three consecutive beats. The minimum 
SBP change between pulse intervals that was accepted was 1 mmHg. BRS (in ms/mmHg) was 
calculated as the mean of all +PI/+SBP and -PI/-SBP slopes. 
 
Statistical analysis 
All analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC). Because of the 
influence of cardiac arrhythmias on pulse rate variability, analyses were restricted to 
participants without previously diagnosed cardiac arrhythmia. In a subgroup analysis of this 
sample, we performed a supplementary set of analyses excluding people with an RMSSD of 
>100 ms as these values may be indicative of unknown cases of atrial fibrillation.33 Factors 
that were associated with CVAF variables were identified by multiple ordinary linear 
regression and quantile regression. The latter is a statistical approach that examines predictors 
of different percentiles of a response variable. While ordinary linear regression models only 
the mean of a dependent variable, quantile regression can model any part of the distribution of 
it, thus giving more comprehensive results.34 For this technique, we assessed relationships in 
19 percentile groups (5 percentiles apart) ranging from the 5th to the 95th percentile (that is, 
the 5th, 10th, 15th,…, 90th and 95th percentiles). Linearity of these associations was checked in 
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each percentile group of the response (CVAF) variable. To evaluate whether the regression 
coefficients varied across the quantiles, we used the qinteract option in PROC QUANTREG. 
We compared quantile regression results with those from ordinary linear regression; this 
approach has been applied in other studies that utilise quantile regression34 and allows a 
comparison with other HRV studies that use ordinary linear regression. These multivariable 
relationships were adjusted for age, sex, ethnicity and use of antihypertensive medicines 
(none, non-beta-blockers or beta-blockers). A two-tailed P<0.05 was considered statistically 
significant. 
 
Results 
Table 1 shows the characteristics of the participants, which comprised 4,167 people. Figures 
1-3 show differences in CVAF measures (Figure 1 for RMSSD, Figure 2 for SD pulse 
intervals and Figure 3 for BRS) per unit difference (or across groups for categorical variables) 
in demographic/clinical factors by percentile of the CVAF measure. Table 2 lists these effect 
sizes for selected percentiles (10th and 90th) and tabulates effect sizes estimated by ordinary 
linear regression. Age was inversely related to both RMSSD up to the 60th percentile of this 
parameter and SD of pulse intervals up to the 45th percentile. But at higher percentiles, the age 
coefficients markedly increased, becoming positive (both P<0.0001 for trend). Compared to 
females, males had lower RMSSD and SD of pulse intervals at low-middle percentiles (≤60th) 
of these parameters but higher levels at high percentiles (P=0.0006 and 0.03, respectively). 
Relative to Europeans, Pacific people had higher RMSSD at upper percentiles of this 
parameter and lower SD of pulse intervals at low percentiles. Maori ethnicity was associated 
with higher RMSSD and SD of pulse intervals at high percentiles especially. South Asian 
ethnicity was unrelated to the three CVAF parameters. Brachial SBP, brachial DBP and peak 
reservoir BP had inverse relationships with BRS that were greater at higher percentiles, with 
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the maximum quantile-specific slope increase being nearly 10-fold in each case (P<0.0001, 
P=0.001 and P=0.002, respectively, for trends). AIx was positively associated with all three 
CVAF variables (at most or all quantiles) but especially so at higher quantiles (all P<0.0001); 
the greatest increase in coefficients was about 11, 12 and 10 times for RMSSD, SD of pulse 
intervals and BRS, respectively. Excess pressure integral was positively associated with BRS 
between the 75th and 85th percentiles only (P=0.01 for trend across all quantiles). BMI was 
unrelated to SD of pulse intervals at low levels of this CVAF parameter but had increasingly 
positive associations at higher percentiles. Conversely, BMI had increasingly inverse 
relationships with BRS at higher percentiles of this CVAF measure (maximum slope 
difference = 13-fold; P=0.004). Diabetes was associated with a lower RMSSD up to the 65th 
percentile of the latter and SD of pulse intervals up to the 30th percentile. Compared to 
percentile-specific coefficients determined from quantile regression (Figures 1-3), regression 
coefficients estimated by ordinary linear regression (Table 2) noticeably differed in magnitude 
often (by >3 times in several cases) and differed in direction sometimes. 
In a subgroup analysis of this sample, we excluded people (n=385) with an RMSSD of 
>100 ms, which may be indicative of unknown cases of atrial fibrillation, and repeated the 
ordinary linear and quantile regression analyses (Supplementary Table S1, Supplementary 
Figures S1-S3). As shown in these results, for RMSSD and SD of pulse intervals, the slopes 
at high percentiles of these parameters generally deviated less from those at lower percentiles. 
Age was still inversely related to RMSSD at lower percentiles of this parameter but now even 
more so at higher quantiles (P=0.002), with the greatest slope increase being by a factor of 
nearly 3. Male sex was still associated with lower RMSSD and SD of pulse intervals at low 
quantiles but now increasingly so (up to 6- and 11-fold slope differences, respectively) at 
higher quantiles (P=0.005 and 0.02, respectively, for overall trends). For BRS, the quantile-
11 
 
plot trends were similar in the subgroup analysis sample (Supplementary Figures S1-S3) 
compared to in the total sample (Figures 1-3). 
 
Discussion 
This study showed that, among people without cardiac arrhythmias, age, sex, Pacific and 
Maori ethnicity, BP variables, BMI and diabetes were associated with CVAF parameters. But, 
in many cases, these associations varied along the distributions of CVAF measures, becoming 
stronger at higher percentiles and sometimes changing direction. 
In several cases, slopes for each percentile were noticeably different from those 
obtained from ordinary linear regression. For instance, we reported that, across percentiles, 
slopes increased by up to more than 10-fold and even changed direction in some cases (Table 
2 and horizontal lines in Figures 1-3). This indicates that, rather than reliance on ordinary 
linear regression, quantile regression provides a more comprehensive assessment of factors 
associated with CVAF. 
Ordinary linear regression relies on meeting assumptions of linearity of associations 
and both homoscedasticity and normality of regression residuals. Because our observed 
relationships differed by levels of the HRV outcome, ordinary linear regression would be 
invalid or inadequate by violating these assumptions. The importance of this problem to HRV 
studies is increased by the finding that these assumptions are often not tested prior to 
presenting results of linear regression.35 In contrast, quantile regression does not need 
assumptions about the distribution of the residuals and is not influenced by outliers or 
skewness in the distribution of the response variable.36-38 Thus, in addition to being more 
informative than ordinary linear regression for studying HRV, quantile regression is a more 
adequate or valid statistical method. 
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At low percentiles of RMSSD and SD pulse intervals, these response variables were 
inversely associated with age (which concurs with previous HRV studies 10) and were lower 
in males. However, these relationships were positive at higher percentiles (Table 2, Figures 1-
2). Given that cardiovascular disease/events correlate positively with HRV parameters at high 
levels of these measures 3,13 but inversely at lower levels, 1,3,5 this suggests that these age- and 
sex- related variations in pulse rate variability parameters may contribute to the increased risk 
of cardiovascular disease observed among older people and males. 
Polynesian and South Asian people experience greater cardiovascular disease 
morbidity compared to white populations.15,16 Given that CVAF measures predict 
cardiovascular events,1-3 ethnic differences in these parameters might contribute to this 
discrepancy in cardiovascular disease burden. However, there is a lack of knowledge about 
whether these measures vary between these ethnic groups. In this study, these parameters did 
not vary between South Asian and European groups, suggesting that they might not mediate 
differences in cardiovascular burden between these populations. In contrast, relative to 
Europeans, Maori people had higher RMSSD and SD of pulse intervals at high percentiles of 
these parameters, while Pacific people had higher RMSSD at high percentiles and lower SD 
of pulse intervals at low percentiles (Table 2, Figures 1-2). Thus, these differences could 
contribute to the higher cardiovascular disease burden observed in Polynesian populations. 
Age and BMI both associate inversely with BRS.11 The present study extends this 
prior research by showing that the sizes of these relationships vary across the BRS 
distribution (Figure 3). In addition, while previous studies have shown that BRS decreases 
with brachial SBP,11 which is supported by the present study, our findings also show that its 
relationships with brachial SBP, brachial DBP and peak reservoir BP are increasingly inverse 
at higher BRS percentiles (Figure 3). We further add to this past work by demonstrating that 
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AIx is positively related to BRS at high percentiles of the latter but not at low percentiles 
(Figure 3). 
As for limitations of this study, the observational design (cross-sectional) precludes 
causal inferences. The CVAF measures were collected over typically 10-12 seconds and, 
while several studies demonstrate that time-domain measures (especially RMSSD) calculated 
from 10-second recordings reliably estimate HRV, a longer sampling interval (typically 5-
minute) is preferable.25-29 Nevertheless, our results are consistent with those of previous 
studies that investigated correlates of parameters from ≥5-minute HRV recordings, which 
supports the validity of our HRV measures. For instance, in line with prior research, our 
results (Table 2, Figures 1 and 3) showed that, at most percentiles, RMSSD decreased with 
age 10 and was lower among diabetics,12 while BRS decreased with age, brachial BP and 
BMI.11 
In summary, we observed that age, sex, Pacific and Maori ethnicity, BP variables, 
BMI and diabetes were related to CVAF measures but these associations varied across CVAF 
percentiles. The quantile-dependency of these relationships could account, at least in part, for 
the skewed distributions observed with CVAF measures. In addition, they highlight the 
importance of quantile regression in examining these associations and that prior studies which 
relied on ordinary linear regression are likely to have not captured these variations by 
percentile. 
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Figure captions 
 
Figure 1 Point estimates and 95% confidence intervals (shaded areas) for differences in 
root mean square of success differences (RMSSD) per unit difference in 
demographic/clinical factors (adjusted for age, sex ethnicity and 
antihypertensive use). The horizontal line represents the point estimate derived 
from ordinary linear regression. EPI = Excess pressure integral. The RMSSD 
values (ms) at each of the 19 percentiles (x-axis coordinates) are 8.5 (5th 
percentile), 10.5, 12.2, 13.8, 15.1, 16.6, 18.0, 19.4, 21.0, 22.7 (median), 24.7, 
26.9, 29.4, 32.7, 37.1, 43.4, 54.8, 87.4 and 213.1 (95th percentile) 
Figure 2 Point estimates and 95% confidence intervals (shaded areas) for differences in 
standard deviation of pulse intervals (SDPI) per unit difference in 
demographic/clinical factors (adjusted for age, sex ethnicity and 
antihypertensive use). The horizontal line represents the point estimate derived 
from ordinary linear regression. EPI = Excess pressure integral. The SDPI 
values (ms) at each of the 19 percentiles (x-axis coordinates) are 4.3 (5th 
percentile), 5.3, 6.2, 6.9, 7.7, 8.6, 9.5, 10.5, 11.6, 12.9 (median), 14.6, 16.7, 
18.8, 22.2, 26.0, 30.2, 38.2, 55.1 and 98.6 (95th percentile) 
Figure 3 Point estimates and 95% confidence intervals (shaded areas) for differences in 
baroreflex sensitivity (BRS) per unit difference in demographic/clinical factors 
(adjusted for age, sex ethnicity and antihypertensive use). The horizontal line 
represents the point estimate derived from ordinary linear regression. EPI = 
Excess pressure integral. The BRS values (ms/mmHg) at each of the 19 
percentiles (x-axis coordinates) are 0.93 (5th percentile), 1.35, 1.72, 2.03, 2.38, 
2.71, 3.02, 3.40, 3.84, 4.23 (median), 4.67, 5.27, 5.79, 6.48, 7.54, 8.79, 10.09, 
12.65 and 17.59 (95th percentile) 
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Table 1. Characteristics of participants 
Variable   N (%) or mean ± 
standard deviation* 
Age (years)   65.9 ± 8.2 
Male Male  2,348 (56) 
Female  1,819 (44) 
Ethnicity European  3,419 (82) 
Maori  227 (5) 
Pacific  303 (7) 
South Asian  218 (5) 
Brachial SBP (mmHg)   139.2 ± 18.7 
Brachial DBP (mmHg)   78.2 ± 10.2 
Augmentation index (%)   28.7 ± 12.2 
Excess pressure integral (mmHg.s)   3.89 ± 1.80 
Peak reservoir BP (mmHg)   122.0 ± 16.4 
Pulse rate (beats/minute)   63.3 ± 10.0 
BMI (kg/m2)   28.4 ± 5.1 
Diabetes (n (%)) Yes  490 (12) 
No  3,677 (88) 
Antihypertensive use (n (%)) None  2,664 (64) 
Non-β-blocker  1,079 (26) 
β-blocker  424 (10) 
RMSSD (ms), median ± IQR   22.7 ± 22.0 
SD of pulse intervals, median ± IQR   12.9 ± 18.3 
BRS (ms/mmHg), median ± IQR   4.2 ± 5.2 
Abbreviations: BMI, body mass index; BP, blood pressure; BRS, baroreflex sensitivity; DBP, 
diastolic BP; IQR, interquartile range; RMSSD, root mean square of successive differences; 
SBP, systolic BP; SD, standard deviation. *Unless otherwise indicated. 
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Table 2. Regression coefficients of cardiovascular autonomic function predictors estimated 
by ordinary linear regression or quantile regression 
Outcome Independent variable Regression coefficient (95% confidence interval) 
OLR 10th percentile 90th percentile 
RMSSD 
(ms) 
Age (years) 1.12 (0.72, 1.53) -0.12 (-0.18, -0.09) 3.17 (2.50, 4.04) 
Sex†              Male 10.15 (3.94, 16.37) -1.32 (-1.97, -0.49) 17.19 (3.65, 37.30) 
Ethnicity†      Pacific 8.67 (-3.43, 20.80) -0.61 (-2.39, 0.17) 16.87 (4.04, 45.42) 
                      Maori 19.04 (5.27, 32.81) 0.58 (-1.36, 1.76) 57.89 (16.32, 136.08) 
                     South Asian -7.56 (-21.64, 6.53) 0.14 (-0.79, 1.82) -5.57 (-21.62, 28.02) 
Brachial SBP (mmHg) -0.08 (-0.24, 0.09) -0.01 (-0.03, 0.01) -0.15 (-0.43, 0.27) 
Brachial DBP (mmHg) -0.18 (-0.13, 0.48) -0.01 (-0.06, 0.01) 0.11 (-0.51, 0.67) 
Augmentation index (%) 0.40 (0.12, 0.68) 0.15 (0.13, 0.19) 1.12 (0.21, 1.69) 
EPI (mmHg.s) -0.53 (-2.35, 1.29) 0.59 (0.33, 0.79) 0.13 (-2.08, 5.12) 
Peak reservoir BP (mmHg) -0.06 (-0.25, 0.13) 0.02 (-0.00, 0.03) -0.14 (-0.48, 0.27) 
BMI (kg/m2) -0.40 (-0.26, 1.06) -0.06 (-0.11, 0.00) 0.49 (-0.37, 2.40) 
Diabetes -4.53 (-14.58, 5.52) -1.70 (-2.67, -1.03) -4.58 (-42.47, 45.95) 
Standard 
deviation of 
pulse 
intervals 
(ms) 
Age (years) 0.39 (0.24, 0.53) -0.07 (-0.09, -0.05) 1.59 (1.26, 1.98) 
Sex†               Male -1.74 (-0.45, 3.93) -0.46 (-0.73, -0.17) 8.34 (1.33, 14.97) 
Ethnicity†      Pacific 4.68 (0.42, 8.95) -0.71 (-1.46, -0.04) 14.66 (-1.43, 33.40) 
                      Maori 8.16 (3.31, 13.00) 0.46 (-0.85, 1.03) 27.04 (6.15, 48.43) 
                      South Asian -2.22 (-7.17, 2.74) -0.07 (-0.57, 0.18) -8.79 (-13.49, 6.84) 
Brachial SBP (mmHg) -0.00 (-0.06, 0.06) -0.00 (-0.01, 0.01) 0.00 (-0.16, 0.21) 
Brachial DBP (mmHg) 0.11 (0.00, 0.22) -0.01 (-0.01, 0.01) 0.35 (-0.03, 0.59) 
Augmentation index (%) 0.19 (0.10, 0.29) 0.06 (0.04, 0.07) 0.38 (0.01, 0.71) 
EPI (mmHg.s) 0.08 (-0.57, 0.72) 0.17 (0.01, 0.24) 1.43 (-1.80, 3.43) 
Peak reservoir BP (mmHg) -0.01 (-0.07, 0.06) 0.01 (-0.00, 0.02) -0.03 (-0.25, 0.20) 
BMI (kg/m2) 0.33 (0.09, 0.56) -0.01 (-0.05, 0.02) 0.89 (0.62, 1.61) 
Diabetes -1.39 (-4.93, 2.15) -0.71 (-1.18, -0.07) 0.55 (-10.94, 14.70) 
Baroreflex 
sensitivity 
(ms/mmHg) 
Age (years) -0.05 (-0.08, -0.03) -0.03 (-0.04, -0.03) -0.08 (-0.17, -0.02) 
Sex†              Male 0.06 (-0.31, 0.43) -0.15 (0.32, 0.02) 0.31 (-0.84, 1.53) 
Ethnicity†      Pacific 0.03 (-0.70, 0.77) -0.08 (-0.36, 0.20) 0.29 (-1.11, 2.66) 
                      Maori 0.62 (-0.21, 1.45) 0.03 (-0.46, 0.25) 2.35 (-0.68, 5.31) 
                      South Asian 0.06 (-0.78, 0.91) 0.08 (-0.17, 0.51) 0.42 (-1.95, 5.36) 
Brachial SBP (mmHg) -0.03 (-0.04, -0.02) -0.01 (-0.02, -0.01) -0.06 (-0.09, -0.03) 
Brachial DBP (mmHg) -0.04 (-0.06, -0.03) -0.01 (-0.02, -0.01) -0.09 (-0.14, -0.05) 
Augmentation index (%) 0.03 (0.02, 0.05) -0.01 (-0.01, -0.00) 0.13 (0.07, 0.17) 
EPI (mmHg.s) 0.11 (-0.00, 0.23) -0.06 (-0.12, 0.00) 0.32 (-0.03, 0.67) 
Peak reservoir BP (mmHg) -0.03 (-0.04, -0.02) -0.01 (-0.02, -0.01) -0.07 (-0.10, -0.04) 
BMI (kg/m2) -0.06 (-0.10, -0.02) -0.01 (-0.02, 0.01) -0.13 (-0.24, -0.03) 
Diabetes -0.48 (-1.08, 0.13) 0.03 (-0.14, 0.29) -0.73 (-2.84, 1.09) 
Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic BP; EPI, excess 
pressure integral; OLR, ordinary linear regression; RMSSD, root mean square of successive 
differences; SBP, systolic BP. All models were adjusted for age, sex ethnicity and 
antihypertensive use. †Reference groups for ethnicity and sex categories are “European” and 
“female”, respectively. 95% confidence intervals that do not encompass zero are in bold. 
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